1.

Low prevalence of human enteropathogenic Yersinia spp. in brown rats (Rattus norvegicus) in Flanders.

2.

Low prevalence of human enteropathogenic Yersinia spp. in brown rats (Rattus norvegicus) in Flanders.

3.

Low prevalence of human enteropathogenic Yersinia spp. in brown rats (Rattus norvegicus) in Flanders.

4.

Low prevalence of human enteropathogenic Yersinia spp. in brown rats (Rattus norvegicus) in Flanders.

5.

Low prevalence of human enteropathogenic Yersinia spp. in brown rats (Rattus norvegicus) in Flanders.

6.

Low prevalence of human enteropathogenic Yersinia spp. in brown rats (Rattus norvegicus) in Flanders.

7.

Low prevalence of human enteropathogenic Yersinia spp. in brown rats (Rattus norvegicus) in Flanders.

1.

Nationwide quality assurance of high-throughput diagnostic molecular testing during the SARS-CoV-2 pandemic: role of the Belgian National Reference Centre.

2.

Nationwide quality assurance of high-throughput diagnostic molecular testing during the SARS-CoV-2 pandemic: role of the Belgian National Reference Centre.

3.

Nationwide quality assurance of high-throughput diagnostic molecular testing during the SARS-CoV-2 pandemic: role of the Belgian National Reference Centre.

4.

Nationwide quality assurance of high-throughput diagnostic molecular testing during the SARS-CoV-2 pandemic: role of the Belgian National Reference Centre.

5.

Nationwide quality assurance of high-throughput diagnostic molecular testing during the SARS-CoV-2 pandemic: role of the Belgian National Reference Centre.

6.

Nationwide quality assurance of high-throughput diagnostic molecular testing during the SARS-CoV-2 pandemic: role of the Belgian National Reference Centre.

7.

Nationwide quality assurance of high-throughput diagnostic molecular testing during the SARS-CoV-2 pandemic: role of the Belgian National Reference Centre.

8.

Nationwide quality assurance of high-throughput diagnostic molecular testing during the SARS-CoV-2 pandemic: role of the Belgian National Reference Centre.

9.

Nationwide quality assurance of high-throughput diagnostic molecular testing during the SARS-CoV-2 pandemic: role of the Belgian National Reference Centre.

1.

Corrigendum to "Risk Assessment of Fishing Trawl Activities to Subsea Pipelines of Sabah and Labuan Waters" ... : تصويب على "تقييم مخاطر أنشطة الصيد بشباك الجر إلى خطوط الأنابيب تح...

2.

Corrigendum to "Risk Assessment of Fishing Trawl Activities to Subsea Pipelines of Sabah and Labuan Waters" ... : تصويب على "تقييم مخاطر أنشطة الصيد بشباك الجر إلى خطوط الأنابيب تح...

3.

Corrigendum to "Risk Assessment of Fishing Trawl Activities to Subsea Pipelines of Sabah and Labuan Waters" ... : تصويب على "تقييم مخاطر أنشطة الصيد بشباك الجر إلى خطوط الأنابيب تح...

1.

Connecting impairment, disability, and handicap in immune mediated polyneuropathies

1.

CLEC4M and STXBP5 gene variations contribute to von Willebrand factor level variation in von Willebrand disease

1.

Three years pilot of spinal muscular atrophy newborn screening turned into official program in Southern Belgium